Companion genetic studies demonstrate that individual genetic deletion of class I HDACs (HDAC1, 2, 3, or 8) does not reduce cancer cell viability, highlighting the redundant function of class I enzymes and supporting the utility of pan-HDAC inhibitors [93]. Here, HDAC9 is linked to cancer.